Canagliflozin and myocardial oxidative stress: SGLT1 inhibition takes centre stage

Eur Heart J. 2021 Dec 21;42(48):4961-4963. doi: 10.1093/eurheartj/ehab519.

Gabriele G Schiattarella^{1

2

3

4}, David Bode^{1

2}

¹ Center for Cardiovascular Research (CCR), Department of Cardiology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
² DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, Berlin, Germany.
³ Translational Approaches in Heart Failure and Cardiometabolic Disease, Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.
⁴ Division of Cardiology, Department of Advanced Biomedical Sciences, Federico II University, Naples, Italy.

No abstract available

Publication types